Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

10 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Circulating granulocyte colony-stimulating factor (G-CSF) levels after allogeneic and autologous bone marrow transplantation: endogenous G-CSF production correlates with myeloid engraftment.
Cairo MS, Suen Y, Sender L, Gillan ER, Ho W, Plunkett JM, van de Ven C. Cairo MS, et al. Among authors: gillan er. Blood. 1992 Apr 1;79(7):1869-73. Blood. 1992. PMID: 1373092
A randomized, placebo-controlled trial of recombinant human granulocyte colony-stimulating factor administration in newborn infants with presumed sepsis: significant induction of peripheral and bone marrow neutrophilia.
Gillan ER, Christensen RD, Suen Y, Ellis R, van de Ven C, Cairo MS. Gillan ER, et al. Blood. 1994 Sep 1;84(5):1427-33. Blood. 1994. PMID: 7520770 Clinical Trial.
Decreased endogenous circulating Steel factor (SLF) levels following allogeneic and autologous BMT: lack of an inverse correlation with post-BMT myeloid engraftment.
Cairo MS, Gillan ER, Weinthal J, Yancik S, van de Ven C, Ho W, Shen V, Buzby JS, Suen Y. Cairo MS, et al. Among authors: gillan er. Bone Marrow Transplant. 1993 Feb;11(2):155-61. Bone Marrow Transplant. 1993. PMID: 7679598
Colony-stimulating factors in the modulation of sepsis.
Gillan E, Plunkett M, Cairo MS. Gillan E, et al. New Horiz. 1993 Feb;1(1):96-109. New Horiz. 1993. PMID: 7922398 Review.
A two-year follow-up of neonates with presumed sepsis treated with recombinant human granulocyte colony-stimulating factor during the first week of life.
Rosenthal J, Healey T, Ellis R, Gillan E, Cairo MS. Rosenthal J, et al. Among authors: gillan e. J Pediatr. 1996 Jan;128(1):135-7. doi: 10.1016/s0022-3476(96)70443-2. J Pediatr. 1996. PMID: 8551404
Effects of phosphodiester and phosphorothioate antisense oligodeoxynucleotides on cell lines which overexpress c-myc: implications for the treatment of Burkitt's lymphoma.
Williams SA, Gillan ER, Knoppel E, Buzby JS, Suen Y, Cairo MS. Williams SA, et al. Among authors: gillan er. Ann Oncol. 1997;8 Suppl 1:25-30. Ann Oncol. 1997. PMID: 9187425
Transverse myelitis after therapy for primitive neuroectodermal tumors.
Ullrich NJ, Marcus K, Pomeroy SL, Turner CD, Zimmerman M, Lehmann LE, Scott RM, Goumnerova L, Gillan E, Kieran MW, Chi SN. Ullrich NJ, et al. Among authors: gillan e. Pediatr Neurol. 2006 Aug;35(2):122-5. doi: 10.1016/j.pediatrneurol.2006.01.013. Pediatr Neurol. 2006. PMID: 16876009
Feasibility of Echocardiographic Techniques to Detect Subclinical Cancer Therapeutics-Related Cardiac Dysfunction among High-Dose Patients When Compared with Cardiac Magnetic Resonance Imaging.
Toro-Salazar OH, Ferranti J, Lorenzoni R, Walling S, Mazur W, Raman SV, Davey BT, Gillan E, O'Loughlin M, Klas B, Hor KN. Toro-Salazar OH, et al. Among authors: gillan e. J Am Soc Echocardiogr. 2016 Feb;29(2):119-31. doi: 10.1016/j.echo.2015.10.008. Epub 2015 Dec 8. J Am Soc Echocardiogr. 2016. PMID: 26678319